LOW-DOSE CHEMOTHERAPY OF METASTATIC BREAST-CANCER WITH CYCLOPHOSPHAMIDE, ADRIAMYCIN, METHOTREXATE, 5-FLUOROURACIL (CAMF) VERSUS SEQUENTIAL CYCLOPHOSPHAMIDE, METHOTREXATE, 5-FLUOROURACIL (CMF) AND ADRIAMYCIN

被引：0
|
作者：
CREECH, RH [1 ]
CATALANO, RB [1 ]
HARRIS, DT [1 ]
ENGSTROM, PF [1 ]
GROTZINGER, PJ [1 ]
机构：
[1] AMER ONCOL HOSP,FOX CHASE CANC CTR,DEPT SURG,PHILADELPHIA,PA 19111
来源：
CANCER | 1979年 / 43卷 / 01期
关键词：
D O I：
10.1002/1097-0142(197901)43:1<51::AID-CNCR2820430107>3.0.CO;2-N
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：51 / 59
页数：9
相关论文
共 50 条
  • [1] COMPARISON OF CYCLOPHOSPHAMIDE, ADRIAMYCIN, AND 5-FLUOROURACIL VERSUS CYCLOPHOSPHAMIDE, METHOTREXATE, AND 5-FLUOROURACIL IN METASTATIC BREAST-CANCER
    BULL, J
    TORMEY, D
    FALKSON, G
    BLOM, J
    PERLIN, E
    CARBONE, P
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1975, 16 (MAR): : 246 - 246
  • [2] CHEMOTHERAPY OF ADVANCED BREAST-CANCER WITH A COMBINATION OF CYCLOPHOSPHAMIDE, ADRIAMYCIN, METHOTREXATE AND 5-FLUOROURACIL (CAMF) WITH AND WITHOUT C-PARVUM
    DEJAGER, R
    PINSKY, C
    KAUFMAN, R
    OCHOA, M
    OETTGEN, H
    KRAKOFF, I
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1976, 17 (MAR): : 296 - 296
  • [3] ADRIAMYCIN, VINCRISTIN, CYCLOPHOSPHAMIDE AND 5-FLUOROURACIL (AVCF) ADJUVANT TREATMENT OF BREAST-CANCER COMPARED TO TREATMENT WITH CYCLOPHOPHAMIDE, METHOTREXATE AND 5-FLUOROURACIL (CMF)
    MATHE, G
    MISSET, JL
    PLAGNE, R
    BELPOMME, D
    LEMEVEL, B
    GUERRIN, J
    FUMOLEAU, P
    METZ, R
    DELGADO, M
    DEVASSAL, F
    ERIGUCHI, M
    SCHNEIDER, M
    REIZENSTEIN, P
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1985, 6 (02) : 168 - 168
  • [4] CLINICAL CONTROLLED TRIAL IN ADVANCED BREAST-CANCER - CMF (CYCLOPHOSPHAMIDE, METHOTREXATE, 5-FLUOROURACIL) VERSUS CMF+T (CYCLOPHOSPHAMIDE, METHOTREXATE, 5-FLUOROURACIL, TAMOXIFEN)
    HINDY, I
    [J]. NEOPLASMA, 1985, 32 (03) : 381 - 387
  • [5] 5-FLUOROURACIL, ADRIAMYCIN, CYCLOPHOSPHAMIDE (FAC) VS 5-FLUOROURACIL, EPIRUBICIN, CYCLOPHOSPHAMIDE (FEC) IN METASTATIC BREAST-CANCER
    LOPEZ, M
    PAPALDO, P
    DILAURO, L
    VICI, P
    CARPANO, S
    CONTI, EMS
    [J]. ONCOLOGY, 1989, 46 (01) : 1 - 5
  • [6] A COMPARISON OF CYCLOPHOSPHAMIDE, ADRIAMYCIN, AND 5-FLUOROURACIL (CAF) AND CYCLOPHOSPHAMIDE, METHOTREXATE, 5-FLUOROURACIL, VINCRISTINE, AND PREDNISONE (CMFVP) IN PATIENTS WITH ADVANCED BREAST-CANCER
    SMALLEY, RV
    LEFANTE, J
    BARTOLUCCI, A
    CARPENTER, J
    VOGEL, C
    KRAUSS, S
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1983, 3 (02) : 209 - 220
  • [7] 5-FLUOROURACIL, ADRIAMYCIN AND CYCLOPHOSPHAMIDE (FAC) COMBINATION CHEMOTHERAPY FOR METASTATIC BREAST-CANCER
    BLUMENSCHEIN, GR
    CARDENAS, JO
    LIVINGSTON, RB
    EINHORN, LH
    FREIREICH, EJ
    GOTTLIEB, JA
    [J]. CLINICAL RESEARCH, 1975, 23 (03): : A336 - A336
  • [8] ADRIAMYCIN, VINCRISTINE, CYCLOPHOSPHAMIDE AND 5-FLUOROURACIL (AVCF) COMPARED WITH CYCLOPHOSPHAMIDE, METHOTREXATE AND 5-FLUOROURACIL (CMF) IN PREMENOPAUSAL BREAST-CARCINOMA - PERSONAL RESULTS
    MATHE, G
    MISSET, JL
    PLAGNE, R
    REIZENSTEIN, P
    BELPOMME, D
    LEMEVEL, B
    GUERRIN, J
    FUMOLEAU, P
    METZ, R
    DELGADO, M
    DEVASSAL, F
    ERIGUCHI, M
    SCHNEIDER, M
    [J]. DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, 1986, 12 (1-3) : 143 - 145
  • [9] COMBINATION CHEMOTHERAPY WITH CMF (CYCLOPHOSPHAMIDE, METHOTREXATE, 5-FLUOROURACIL) VERSUS CNF (MITOXANTRONE, 5-FLUOROURACIL, CYCLOPHOSPHAMIDE) IN ADVANCED BREAST-CANCER - A MULTICENTER RANDOMIZED STUDY
    LORUSSO, V
    VICI, P
    BIANCO, AR
    LOPEZ, M
    DEPLACIDO, S
    PIANO, A
    PALOMBA, G
    CARLOMAGNO, C
    DAPRILE, M
    FOSSER, V
    BRANDI, M
    DELENA, M
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 1993, 2 (04) : 531 - 535
  • [10] Cyclophosphamide, methotrexate and infusional 5-fluorouracil (infusional CMF) in metastatic breast cancer
    O'Byrne, KJ
    Koukourakis, MI
    Saunders, MP
    Salisbury, AJ
    Isaacs, R
    Varcoe, S
    Taylor, M
    Ganesan, TS
    Harris, AL
    Talbot, DC
    [J]. BRITISH JOURNAL OF CANCER, 1998, 77 (11) : 1950 - 1956
12345